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IN the course of our work with progesterone and two 19-nor-contraceptives
marked pathological changes in the uterus have been noticed. Each of these
compounds acts on the uterus somewhat differently from the others. Thus a
comparative discussion of these uterine changes offers considerable interest. The
interest such a comparative discussion deserves is all the greater as more recently
uterine changes induced by contraceptives have been noticed also in women
(Charles. 1964).
Endometriosis of cystic glands
The steroids were administered by subcutaneous implantation of pellets. For
details see our preceding papers (Lipschutz, Iglesias, Panesevich and Salinas.
1967a, b).
In experiments lasting 13 months the toxic action of progesterone (P) on the
uterus becomes highly pronounced. The volume of the uterus is greatly increased
and the weight may reach 550 mg., i.e. about ten times that of the normal organ
(Table I). The weight of the uterus is certainly rather a vague index of the vari-
iable changes occurring in this organ. However, the figures in Table I show at a
glance the toxic action of P and of the two contraceptives, norethindrone and
norethynodrel, on the uterus.
With 665 or 900 ,ug./day of P administered during 13 months the outer surface
of the uterus is covered with bulb-like formations. These are cystic glands which
have penetrated into the muscular layers and finally reached the surface of the
uterus. This kind of endometriosis was present in almost all animals receiving
665 or 900 ,ag./day (Table I; Fig. 2). In the group with 117 pug./day there was
but 1 animal with endometriosis and it did not reach the pattern characteristic
of larger quantities of P (compare Fig. 1 and 2).
When the administration of P was prolonged for 18 months cystic glands and
endometriosis arose with smaller quantities ofP. As just mentioned endometriosis
was present but in 1 out of 10 animals receiving 117 ptg./day ofP during 13 months;
on the contrary, in experiments with the same quantity ofP but lasting 18 months
endometriosis was present in almost all the animals of the group. Endometriosis
was present in a considerable percentage also of animals receiving only 59 ,tg./day
of P during 18 months.
The great increase of incidence of endometriosis with the increase of P perUTERINE CHANGES INDUCED IN MICE BY CONTRACEPTIVES
TABLE L.-243 Animals Treated During 13 or 18 Months with P and 19-nor-
contraceptives, Compared with 33 Normal Animals ofthe Same Age
Age No. ofanimals Uterine weight
at , A - < A Oestrous
Treatment necropsy With Average Range C
Steroid psg./day (months) (months) Total endometriosis mg. mg. %
P 117 13 16 10 1 148t 122-170 0
P 665-900 13 16 21§ 20 303J 98-550 0
P 9-29 18 20-21 76 0 108 32-184** 32
P 59 18 21 28 8 185 104-284 0
P 117 18 21 18t 15 233 119-585 0
P 665 18 21* 18¶1 17 198 54-504 0
P 900 18 20 16 15 333 123-788 0
N-drone 7 7 18 20 25 20 224 132-310 24
N-drel 5 5 17J-19 19f-211 2111 10 136 41-388 54
0 0 0 21-22 33 0 76 23-220tt 43
* 6 animals 23 months old; see Table III of our previous paper (Lipschutz et al. 1967b).
t group of 19; 1 animal no histology of uterus.
$ 1 animal no uterine weight.
§ group of 22; 1 animal no pellet found at necropsy; the unique animal with C.
¶ group of 20; 2 animals no histology of uterus.
II group of 24; 3 animals no histology of uterus.
** omitted 1 animal (Fig. 10).
tt Uteri with high weights: ovarian cysts, or haemorrh. foll., haemorrh. swamps as occurring
sometimes in old animals (Lipschutz, 1960).
day is impressive: from 0 in the groups of9-29,ug./day, to 30 per cent in the group
of 59 ,ug./day; and finally to about 95 per cent in the groups with 117 to 900 jug./
day of P.
Endometriosis occurred also with the two contraceptives. As summarized in
Table I the great increase of uterine weight and endometriosis were present in
20 out of 25 animals receiving an average of but 7'7 ,ug./day of norethindrone
(Fig. 3), and in halfofthe animals with an average of5*5 ,ug./day ofnorethynodrel
(Fig. 4). However, only rarely was the pattern reached which predominates with
very large quantities of P as in Fig. 2. The difference between norethindrone
and norethynodrel was striking.
It is well known that endometriosis occurs also under the prolonged influence
of oestrogens. But a picture similar to that offered by the uterus under the
prolonged influence of P has never been seen with oestrogens. One may wonder
how far progesterone and oestrogen have combined in action when producing this
extraordinary type of endometriosis. There was indeed the fact that the oestro-
genic influence on the vagina was blocked in all the groups with large quantities
of P: there were among 33 aged normal animals 43 per cent in oestrous, and not
a single animal of the same age in oestrous among 80 animals receiving 59 to
900#tg./day ofP. However, this fact would not allow any conclusion as to antago-
nizing of other oestrogenic actions, as evidenced by the condition of the endo-
metrial and glandular epithelium: both kept their normal aspect in experiments
with P or norethindrone.
The epithelium of the cystic glands may even become very flattened. But
this is most probably due to the intraglandular pressure.
Cystic uterine glands have been seen recently also in rabbits treated during
33 months with hydroxyprogesterone caproate (Meissner and Sommers, 1966).
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Metaplasia of the endometrial and glandular epithelium induced by norethynodrel
We referred to the condition of the endometrial and glandular epithelium in
experiments with P and norethindrone which seemingly keep their normal aspect
or may become even flattened. With norethynodrel we became acquainted with
a new unexpected phenomenon: the metaplasia ofboth these epithelial structures.
Metaplasia of the epithelium of the endometrium or of the glands or of both
was found in 6 out of24 animals with norethynodrel. A good example is shown in
Fig. 5 where both are in metaplasia. In Fig. 6 only the epithelium of the endo-
metrium is in metaplasia whereas the glands are seemingly intact. In Fig. 7
there is a gland in endometriosis which underwent metaplasia.
Neither with P nor with norethindrone was metaplasia induced. This is an
other proof of the differential toxic action of the various 19-nor-steroids used as
contraceptives.
EXPLANATION OF PLATES
FIG. 1. Endometriosis. 398 days, 117 pg./day of P (8959). Uterus 162 mg. A, X 10.
B, x34.
FIG. 2. Endometriosis of cystic glands. 397 days, 665 pg./day of P. A, Uterus: 484 mg.
x 10 (8818). B, Uterus: 430 mg. x 34 (8825). Glands protruding to outside the uterus.
FIG. 3.-Endometriosis. 538 days, 8-4 pg./day of norethindrone (9357). Uterus: 285 mg.
x 10. Pattern of endometriosis similar to that of Fig. 1, though more pronounced. See
also tumour of endometrial stroma (Fig. 15).
FIG. 4.-Endometriosis. 565 days, norethynodrel, A, 5*0 jig./day (9153). Uterus: 165 mg.
xIO. B,5-6pg./day(9188). Uterus: 123mg. x34.
FIG. 5. Metaplasia of the endometrial and glandular epithelium. 565 days, 4-5 ,ug./day of
norethynodrel (9145). Uterus: 60 mg. x 195.
FIG. 6.-Metaplasia of the endometrial epithelium. 567 days, 5*3 pg./day of norethynodrel
(9173). Uterus: 129 mg. x 390.
FIG. 7.-Metaplasia of glandular epithelium; endometriosis. 567 days 4 0 pg./day of nore-
thynodrel (9172). Uterus: 95 mg. x 100.
FIG. 8. Tiny sarcoma ofthe endometrial stroma. 553 days, 117 pg./dayofP (8982). Uterus:
368 mg. A, x 34. B, X 195. c, x 390. Both round cells and spindle shaped cells present,
the latter seemingly predominating.
FIG. 9.-Small sarcoma in the endometrial stroma. 554 days, 900 pg./day of P. (9032).
Uterus: 505 mg. A, x 34. B, x 390. Round cells prevailing. Giant cells.
FIG. 10. Largest tumour ofendometrial stroma. 554 days, 18 pg./day ofP (8088). A, x 3-5.
B, x 390. Round cells and spindle shaped cells. c, x 390. Fibroblasts predominating.
FIG. 11.-" Galaxy " of six tiny sarcomata of the endometrial stroma. 554 days, 665 pg./day
of P (8867). Uterus: 246 mg. x 195.
FIG. 12. Sarcomata of the endometrial stroma accompanying glands in endometriosis.
554 days, 900 pg./day of P (9033). Uterus: 130 mg. A, X 100, and B, x 390. Tiny focus
between the circular and longitudinal muscular layers.
FIG. 13.-Two tumours of the endometrial stroma. 537 days, 8-2 pg./day of norethindrone
(9367). Uterus: 228 mg. A, x 34. B, X 195. The top tumour: round cells and spindle
shaped cells. c, x 195. The bottom tumour: spindle shaped or fibrous type prevailing.
FIG. 14.-Two tiny sarcomata of the endometrial stroma. 538 days, 13 pg./day of norethin-
drone (9343). Uterus: 208 mg. x 195.
FIG. 15.-Sarcoma of the endometrial stroma. 538 days, 8-4 pg./day of norethindrone (9357).
Same animal as Fig. 3. Uterus: 285 mg. A, X 34. B, x 390. Round cells and spindle
shaped cells. Giant cells.
FIG. 16.-Microcellular foci of the endometrial stroma. 551 days, 59 ,ug./day of P. (8400).
Uterus: 223 mg. A, x 34. Many foci, both intramuscular and of the endometrial stroma
are seen. B, x 100 and c, x 390. The double focus on the top. D, X 390. The focus of
the endometrial stroma, beneath. A well conserved uterine gland amid the microcellular
focus.
FIG. 17.-Microcellular focus between the two muscular layers of the uterine wall. 551 days,
59 pug./day of P (8394). Uterus: 154 mg. A, X 195. B, x 390. Uterine gland in
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One might be inclined to explain these changes occurring in the endometrial
and glandular epithelium by the conversion of 19-norgestagens into oestrogen
(Okada, Amatsu, Ishihara and Tokuda, 1064; Paulsen, 1965). However, the
metaplasia as induced with norethynodrel does not lead to keratinisation of the
glandular epithelium as seen in animals of the same strain with subtotal castra-
tion causing an ovarian-hypophyseal imbalance (Lipschutz, 1960).
Sarcoma induced by P and norethindrone in the endometrial stroma
A tumour of spindle-shaped cells appeared in the endometrial stroma in 1
out of 32 animals receiving during 13 months 117 to 900 ,ug./day of P (Lipschutz,
Iglesias, Panasevich and Salinas, 1966). This animal received 665 ,ug./day of P.
Subsequently similar tumours were found in 15 out of the 142 animals having
been treated during 18 months with P and having absorbed 18 to 900 ,ug./day
(Table II).
There can scarcely be any doubt that these tumours are sarcomata (see
Discussion). They are mostly tiny structures (Fig. 8, 9). Strangely enough,
the largest tumour was found in an animal belonging to the series receiving only
18 ,ug./day (Fig. 10). But the incidence of these tumours of the endometrial
stroma increased greatly with an increasing quantity ofP (Table II). In the group
with 665 /,g./day in 3 out of 4 animals with sarcoma there were several of these
tumours, sometimes forming a kind of " galaxy " (Fig. 11).
The sarcoma was found in 7 cases in the vicinity of glands in endometriosis.
The " galaxy " in Fig. 11 is in endometriosis. An illustrative picture of this site
of the sarcomata is given in Fig. 12.
The same tumour was also found in 4 out of25 animals receiving 8 to 16 /,g./day
of norethindrone (Fig. 13-15). With these quantities of norethindrone incidence
of the tumour of the endometrial stroma was almost as great as with 117 to 900
TABLE II.
The same animals as in Table I.
Number of animals
Age at
ug./day Treatment necropsy With Other foci in
P (months) (months) Total sarcoma the uterine wall
117 . 13 . 16 10 0 0
665 . 13 . 16 11 1 0
900 . 13 16 10 0 0
9 18 20-21 17 0 0
18 18 20-21 15 1t 0
29 18 . 21 44 1 2
59 . 18 . 21 . 28 2 3
117 . 18 21 . 19 4 1
665 18 20-21* 204+ 1
900 . 18 . 21 16 3§ 1
N-drone 18 . 20 . 25 4 1
N-drel 171-19 . 19-21- . 24 0 1
* 1 animal 23 months. t with the largest tumour (Fig. 10)
+ 3 animals with several tiny sarcomata.
§ 1 animal with several tiny sarcomata.
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,ug./day of P: 16 per cent of animals with 4-16 ,ug./day of norethindrone; and
20 per cent of animals with 117 to 665#zg./day of P (11, out of 55 animals, with
uterine sarcoma).
No animal with norethynodrel showed a tumour of the endometrial stroma.
In 8 animals pertaining to the different groups with P there were in the uterine
wall also foci of cells different from those of the sarcomata (Table II). The uteri
of 2 ofthese animals are shown in Fig. 16 and 17. The focus is located preferably
between the two muscular layers of the uterine wall but also in the endometrial
stroma. Several double foci of this type may also be present (Fig. 16). These
tumours occurred also in 1 animalreceiving norethindrone andin 1 animalreceiving
norethynodrel.
DISCUSSION
The occurrence of uterine tumours induced in mice by progesterone and 19-
nor-contraceptives has to be considered as a definite fact. We shall discuss the
problem of these experimental uterine tumours, leaving aside the endometriosis
of cystic glands, an endometriosis one may call " fantastic " (see Fig. 2; see also
the results of Meissner and Sommers, 1966; in rabbits and their figures 2 and 3).
There is first the sarcoma of the endometrial stroma. The variable size of
the cells and the presence of giant cells and likewise the size of the nuclei and
nucleoli-all this is in favour of the opinion that this experimental tumour of the
endometrial stroma is a sarcoma. Certainly, the tumours vary structurally
between fibrosarcoma, spindle-shaped sarcoma, and round-cell sarcoma (Fig. 8
to 15). Only in the large tumour of Fig. 10 the fibrous part was predominant.
Similar tumours have been found in women receiving 19-nor-progestational
agents (Charles, 1964). Charles describes them as " fibrous stromal reaction ",
" fibroblast-like stromal cells ", " a celular stroma which might be mistaken for
endometrial sarcoma ". Comparing the steroid-induced tumours in mice and
women one cannot avoid the impression that in the laboratory animal the sarco-
matous trend is structurally much more pronounced than in women.
The structural difference ofthese tumours between women and mice is possibly
due to the great difference in the duration of treatment. Our tumours of the
endometrial stroma appeared exceptionally, in 1 case only, in a group of31 animals
treated for 13 months with 117 to 900/sg./day ofprogesterone; but their incidence
increased to 11 out of 55 animals receiving 117 to 900,ug./day of progesterone
during 18 months. The 18 months ofmice correspond to 40 or 45 years in women!
These chronological considerations may render more easy the understanding of
the difference as to the pathological patterns elicited in the endometrial stroma
by contraceptives, in women on one hand, and in our laboratory animals on the
other.
As to the foci of cells, which are certainly different from those of the sarcoma
originating in the endometrial stroma or around glands in endometriosis, classi-
fication is much more difficult than with sarcoma (compare Fig. 16 and 17 with
Fig. 8 to 15). Glands or degenerated rests ofglands are present in the respective
foci both of the endometrial stroma (Fig. 16c) and of the space between the two
muscular layers (Fig. 17B). This makes one suppose that these foci, similarly to
the sarcoma, belong always to the endometrial stroma. Are they sarcomata in a
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SUMMARY
A variety of pathological changes is elicited in the uterus by the prolonged
administration of progesterone and 19-nor-contraceptives.
These pathological changes are: formation of cystic glands; endometriosis,
including that of cystic glands and the appearance of the latter on the surface of
the uterus; tumours of the endometrial stroma varying structurally between
fibrosarcoma and sarcoma; metaplasia of the endometrial and glandular epi-
thelium; foci of cells in the uterine wall possibly on the way to sarcoma.
The pathogenic activity ofthe steroids examined differs considerably: tumours
of the endometrial stroma are produced by progesterone and norethindrone but
not by norethynodrel. On the other hand norethynodrel produces metaplasia
of the endometrial and glandular epithelium whereas progesterone and nore-
thindrone are devoid of this action.
Results obtained with the prolonged administration of progesterone give
evidence that the appearance ofthe various pathological patterns is fundamentally
dependent both on the quantity of the steroid administrated and on the duration
of the administration.
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